117 related articles for article (PubMed ID: 11077219)
1. Transplant vasculopathy: viral anti-inflammatory serpin regulation of atherogenesis.
Lucas A; Dai E; Liu L; Guan H; Nash P; McFadden G; Miller L
J Heart Lung Transplant; 2000 Nov; 19(11):1029-38. PubMed ID: 11077219
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of transplant vasculopathy in a rat aortic allograft model after infusion of anti-inflammatory viral serpin.
Miller LW; Dai E; Nash P; Liu L; Icton C; Klironomos D; Fan L; Nation PN; Zhong R; McFadden G; Lucas A
Circulation; 2000 Apr; 101(13):1598-605. PubMed ID: 10747355
[TBL] [Abstract][Full Text] [Related]
3. Serp-1, a viral anti-inflammatory serpin, regulates cellular serine proteinase and serpin responses to vascular injury.
Dai E; Guan H; Liu L; Little S; McFadden G; Vaziri S; Cao H; Ivanova IA; Bocksch L; Lucas A
J Biol Chem; 2003 May; 278(20):18563-72. PubMed ID: 12637546
[TBL] [Abstract][Full Text] [Related]
4. Neuroserpin, a thrombolytic serine protease inhibitor (serpin), blocks transplant vasculopathy with associated modification of T-helper cell subsets.
Munuswamy-Ramanujam G; Dai E; Liu L; Shnabel M; Sun YM; Bartee M; Lomas DA; Lucas AR
Thromb Haemost; 2010 Mar; 103(3):545-55. PubMed ID: 20135065
[TBL] [Abstract][Full Text] [Related]
5. Virus-encoded serine proteinase inhibitor SERP-1 inhibits atherosclerotic plaque development after balloon angioplasty.
Lucas A; Liu L; Macen J; Nash P; Dai E; Stewart M; Graham K; Etches W; Boshkov L; Nation PN; Humen D; Hobman ML; McFadden G
Circulation; 1996 Dec; 94(11):2890-900. PubMed ID: 8941118
[TBL] [Abstract][Full Text] [Related]
6. Serpins, the vasculature, and viral therapeutics.
Richardson J; Viswanathan K; Lucas A
Front Biosci; 2006 Jan; 11():1042-56. PubMed ID: 16146796
[TBL] [Abstract][Full Text] [Related]
7. Viral cross-class serpin inhibits vascular inflammation and T lymphocyte fratricide; a study in rodent models in vivo and human cell lines in vitro.
Viswanathan K; Bot I; Liu L; Dai E; Turner PC; Togonu-Bickersteth B; Richardson J; Davids JA; Williams JM; Bartee MY; Chen H; van Berkel TJ; Biessen EA; Moyer RW; Lucas AR
PLoS One; 2012; 7(9):e44694. PubMed ID: 23049756
[TBL] [Abstract][Full Text] [Related]
8. Identification of myxomaviral serpin reactive site loop sequences that regulate innate immune responses.
Dai E; Viswanathan K; Sun YM; Li X; Liu LY; Togonu-Bickersteth B; Richardson J; Macaulay C; Nash P; Turner P; Nazarian SH; Moyer R; McFadden G; Lucas AR
J Biol Chem; 2006 Mar; 281(12):8041-50. PubMed ID: 16407226
[TBL] [Abstract][Full Text] [Related]
9. Expression of allograft inflammatory factor-1 is a marker of activated human vascular smooth muscle cells and arterial injury.
Autieri MV; Carbone C; Mu A
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1737-44. PubMed ID: 10894811
[TBL] [Abstract][Full Text] [Related]
10. Myxoma viral serpin, Serp-1, a unique interceptor of coagulation and innate immune pathways.
Viswanathan K; Liu L; Vaziri S; Dai E; Richardson J; Togonu-Bickersteth B; Vatsya P; Christov A; Lucas AR
Thromb Haemost; 2006 Mar; 95(3):499-510. PubMed ID: 16525579
[TBL] [Abstract][Full Text] [Related]
11. The role of fibrinolytic genes and proteins in the development of allograft vascular disease.
Benza RL; Passineau MJ; Anderson PG; Barchue JP; George JF
J Heart Lung Transplant; 2011 Aug; 30(8):935-44. PubMed ID: 21652221
[TBL] [Abstract][Full Text] [Related]
12. Viral serpin, Serp-1, inhibits endogenous angiogenesis in the chicken chorioallantoic membrane model.
Richardson M; Liu L; Dunphy L; Wong D; Sun Y; Viswanathan K; Singh G; Lucas A
Cardiovasc Pathol; 2007; 16(4):191-202. PubMed ID: 17637427
[TBL] [Abstract][Full Text] [Related]
13. Myxoma viral serpin, Serp-1, inhibits human monocyte adhesion through regulation of actin-binding protein filamin B.
Viswanathan K; Richardson J; Togonu-Bickersteth B; Dai E; Liu L; Vatsya P; Sun YM; Yu J; Munuswamy-Ramanujam G; Baker H; Lucas AR
J Leukoc Biol; 2009 Mar; 85(3):418-26. PubMed ID: 19052145
[TBL] [Abstract][Full Text] [Related]
14. Myxomavirus anti-inflammatory chemokine binding protein reduces the increased plaque growth induced by chronic Porphyromonas gingivalis oral infection after balloon angioplasty aortic injury in mice.
Lucas AR; Verma RK; Dai E; Liu L; Chen H; Kesavalu S; Rivera M; Velsko I; Ambadapadi S; Chukkapalli S; Kesavalu L
PLoS One; 2014; 9(10):e111353. PubMed ID: 25354050
[TBL] [Abstract][Full Text] [Related]
15. Blockade of vascular smooth muscle cell proliferation and intimal thickening after balloon injury by the sulfated oligosaccharide PI-88: phosphomannopentaose sulfate directly binds FGF-2, blocks cellular signaling, and inhibits proliferation.
Francis DJ; Parish CR; McGarry M; Santiago FS; Lowe HC; Brown KJ; Bingley JA; Hayward IP; Cowden WB; Campbell JH; Campbell GR; Chesterman CN; Khachigian LM
Circ Res; 2003 May; 92(8):e70-7. PubMed ID: 12690039
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries.
DeYoung MB; Tom C; Dichek DA
Circulation; 2001 Oct; 104(16):1972-1. PubMed ID: 11602503
[TBL] [Abstract][Full Text] [Related]
17. Serine protease inhibitor Serp-1 strongly impairs atherosclerotic lesion formation and induces a stable plaque phenotype in ApoE-/-mice.
Bot I; von der Thüsen JH; Donners MM; Lucas A; Fekkes ML; de Jager SC; Kuiper J; Daemen MJ; van Berkel TJ; Heeneman S; Biessen EA
Circ Res; 2003 Sep; 93(5):464-71. PubMed ID: 12919945
[TBL] [Abstract][Full Text] [Related]
18. Localized delivery of heparin to angioplasty sites with iontophoresis.
Mitchel JF; Azrin MA; Fram DB; Bow LM; McKay RG
Cathet Cardiovasc Diagn; 1997 Jul; 41(3):315-23. PubMed ID: 9213031
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin, a potential vascular regulatory protein, reduces intimal hyperplasia after arterial injury.
Dai E; Stewart M; Ritchie B; Mesaeli N; Raha S; Kolodziejczyk D; Hobman ML; Liu LY; Etches W; Nation N; Michalak M; Lucas A
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2359-68. PubMed ID: 9409202
[TBL] [Abstract][Full Text] [Related]
20. Development of a combined cardiac and aortic transplant model to investigate the development of transplant arteriosclerosis in the mouse.
Ensminger SM; Billing JS; Morris PJ; Wood KJ
J Heart Lung Transplant; 2000 Nov; 19(11):1039-46. PubMed ID: 11077220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
